Literature DB >> 33549387

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

M A Dimopoulos1, P Moreau2, E Terpos1, M V Mateos3, S Zweegman4, G Cook5, M Delforge6, R Hájek7, F Schjesvold8, M Cavo9, H Goldschmidt10, T Facon11, H Einsele12, M Boccadoro13, J San-Miguel14, P Sonneveld15, U Mey16.   

Abstract

Entities:  

Keywords:  clinical practice guidelines; diagnosis; follow-up; multiple myeloma; prognosis; treatment

Year:  2021        PMID： 33549387     DOI： 10.1016/j.annonc.2020.11.014

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  50 in total

Review 1.  Progress of modern imaging modalities in multiple myeloma.

Authors:  Toshiki Terao; Kosei Matsue
Journal:  Int J Hematol       Date:  2022-05-09       Impact factor: 2.490

2.  Treatment of older adult or frail patients with multiple myeloma.

Authors:  Shakira J Grant; Ciara L Freeman; Ashley E Rosko
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 3.  Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma.

Authors:  Linda Heimberg; Stefan Knop
Journal:  Oncol Res Treat       Date:  2021-11-18       Impact factor: 2.825

Review 4.  What's Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma.

Authors:  Bruno Almeida Costa; Tarek H Mouhieddine; Joshua Richter
Journal:  Target Oncol       Date:  2022-06-30       Impact factor: 4.864

5.  Adverse outcome associated with daratumumab-based treatments in relapsed/refractory multiple myeloma patients with amplification of chromosome arm 1q21: a single-center retrospective experience.

Authors:  Roberto Marasca; Mario Luppi; Emiliano Barbieri; Monica Maccaferri; Giovanna Leonardi; Francesca Giacobbi; Giorgia Corradini; Ivana Lagreca; Patrizia Barozzi; Leonardo Potenza
Journal:  Ann Hematol       Date:  2022-09-15       Impact factor: 4.030

6.  Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy : Breaking a dangerous bond.

Authors:  Georg Jeryczynski; Hermine Agis; Sabine Eichinger-Hasenauer; Maria Theresa Krauth
Journal:  Wien Klin Wochenschr       Date:  2022-03-19       Impact factor: 2.275

7.  Case Report: AL Amyloidosis Severe Restrictive Cardiomyopathy Associated With Multiple Myeloma-Diagnostic Difficulties.

Authors:  Yulia Y Kirichenko; Irina S Ilgisonis; Elena S Nakhodnova; Irina Y Sokolova; Olga V Bochkarnikova; Sabina A Kardanova; Olga V Lyapidevskaya; Elena V Privalova; Vladimir I Ershov; Yurii N Belenkov
Journal:  Front Cardiovasc Med       Date:  2022-06-13

Review 8.  Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety.

Authors:  Massimo Offidani; Laura Corvatta; Sonia Morè; Attilio Olivieri
Journal:  Drug Des Devel Ther       Date:  2021-06-02       Impact factor: 4.162

9.  Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma.

Authors:  Andrzej J Jakubowiak; Shaji Kumar; Rohan Medhekar; Huiling Pei; Patrick Lefebvre; Shuchita Kaila; Jianming He; Marie-Hélène Lafeuille; Annelore Cortoos; Anil Londhe; Panagiotis Mavros; Thomas S Lin; Saad Z Usmani
Journal:  Oncologist       Date:  2022-07-05       Impact factor: 5.837

10.  High Carbohydrate Diet Is Associated with Severe Clinical Indicators, but Not with Nutrition Knowledge Score in Patients with Multiple Myeloma.

Authors:  Ema Borsi; Costela Lacrimioara Serban; Cristina Potre; Ovidiu Potre; Salomeia Putnoky; Miruna Samfireag; Raluca Tudor; Ioana Ionita; Hortensia Ionita
Journal:  Int J Environ Res Public Health       Date:  2021-05-19       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.